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Dr Marc A. Passman (Birmingham, Ala). I would like to
congratulate Dr Mehta and his colleagues from Albany, New
York, on an excellent paper, and applaud the program commit-
tee for inviting some cross-regional work onto our Southern
Association for Vascular Surgery (SAVS) program. Over an
8-year experience, the group from Albany performed 1768
endovascular abdominal aortic aneurysm (AAA) repairs, of
which 19.2%, or almost 1 in 5, required some secondary or
tertiary procedure. Interestingly, we just reviewed our endovas-
cular experience at University of Alabama at Birmingham
(UAB), which will be presented at another vascular meeting
later this year. Over a similar time period representing about
1100 stent graft repairs, in our experience only 9.2%, or 1 in 10,
required a secondary procedure, a rate less than half of what was
presented here. I will try to avoid the tempting regional com-
parison that perhaps we know how to do endovascular AAA
repairs more definitively in our Southern region compared with
the great state of New York. Rather, there are likely some
differences in our respective experiences that form the focus of
my questions.
First, you state in the manuscript that stent grafts were per-
formed in both “favorable and unfavorable” conditions, but no
further definition or analysis is provided. Assuming what you term
“unfavorable conditions” relates to more anatomically challenging
situations, were you able to stratify your data set of secondary
procedures within the larger overall endovascular aneurysm repair
population to determine if use in “unfavorable conditions” was a
predictor for stent graft failure and the need for secondary proce-
dure?
Second, because 40% of your secondary procedure needs were
for type II endoleak, much of your data analysis is driven by this
dominant subgroup. Perhaps the overall larger need for secondary
procedures in your study is in part reflective of a more aggressive
approach for type II endoleaks. What percentage of the larger
overall endovascular aneurysm repair population had type II en-
doleaks, and what percentage of these type II endoleaks required a
secondary procedure? Please clarify what criteria are used to inter-
vene for a type II endoleak within your group and if indeed your
approach is more aggressive.
Third, with such a large group of vascular surgeons within the
Albany practice, was there some degree of surgical variability or
perhaps surgeon outliers that accounted for a larger portion of
failed primary endovascular stent graft repairs or need for second-
ary procedures?
Fourth and finally, with such a large reported experience over
an extended time period, there is an opportunity here to look at
time-dependent data. Have you had a chance to look at anysecondary procedures may arise and what type of secondary proce-
dure was required at that time point?
Again, all regional considerations aside, I wish to welcome the
group from Albany to our meeting and appreciate the opportunity
to discuss this paper.
DrManish Mehta. On behalf of The Albany Vascular Group
I would like to thank the Southern Association of Vascular Surgery
for extending us an invitation. Furthermore I would like to thank
Dr Passman for discussing this paper. Marc, I appreciate your
insightful questions and comments. Your question whether we can
predict stent graft failures based on favorable versus unfavorable
conditions is a good one, and currently available data would
suggest that when we treat patients that meet the IFUs for a
particular stent graft, the outcomes tend to be better than patients
that fall outside the IFUs, ie short necks, short/angulated necks,
etc. I can tell you that less than 50% of our aneurysm patient
population would meet the IFUs to be enrolled in currently
ongoing stent graft trials, and would be considered to have favor-
able anatomy.
Unfortunately we did not quantify morphological variables
that would allow us to analyze IFUs per stent graft and match them
to anatomically favorable versus unfavorable characteristics in our
patient population. The goal of our study was to analyze the
outcomes of secondary procedures following endovascular aneu-
rysm repair. Treatment of type 2 endoleaks remains a controversial
issue. At Albany, we have reserved treating type 2 endoleaks in
patients with aneurysm sac size increase of greater than 5mm
following EVAR, and in large abdominal aortic aneurysms greater
than 5.5cm with persistent type 2 endoleaks at greater than 6
months after EVAR. This is a reflection of our experience discov-
ering that up to 20% of aneurysm ruptures following EVAR are
secondary to type 2 endoleaks. Furthermore, there have been
several recent papers suggesting that patient with persistent type 2
endoleaks tend to have worse outcomes over long term follow up.
The translumbar approach for embolization of these endoleaks is a
relatively benign procedure, and so we have considered this as a
viable option in select patients.
To answer your question regarding the surgical variability of a
large number of vascular surgeons in Albany, as you know we have
17 vascular surgeons, but as you also know, we pride ourselves in
developing structured standardized approaches to all procedures
whether they are distal bypass, carotid endarterectomy, or endo-
vascular repair. I think that overall we did not analyze the surgical
variability amongst different partners, and the need for secondary
procedures following EVAR, but my sense would be that there
really would not be much of a difference since we all perform these
procedures in a very similar manner.
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that as we got more experienced, patients would need less
secondary interventions. What I think is happening is that with
gaining significant experience, we are also treating more com-
plex aortoiliac aneurysms by endovascular means, and thislowing EVAR might not change with increasing experience.
The important point that we have learned here is that the risks of
secondary interventions are little under controlled elective cir-
cumstances, when compared to emergent circumstances, so
vigilant patient follow up remains a vital component of endo-would mean that the incidence of secondary interventions fol- vascular aneurysm therapy.
